No Detail Found!

A strategy to improve the solubility and bioavailability of the insoluble drug piperlongumine through albumin nanoparticles

Author(s)
Sen Niu Department of Pharmaceutical Engineering, Xuzhou Pharmaceutical Higher Vocational School of Jiangsu Province,Xuzhou,China
Xurui Li School of Pharmaceutical Sciences, Liaoning University,Shenyang, Liaoning,China
Zhongqiu Guo School of Pharmaceutical Sciences, Liaoning University,Shenyang, Liaoning,China
David Wan Beijing Rule Biopharma, Co., Ltd.,Beijing,China
Yu Liu School of Pharmaceutical Sciences, Liaoning University,Shenyang, Liaoning,China
Li Li School of Pharmaceutical Sciences, Liaoning University,Shenyang, Liaoning,China
Meng Dong School of Pharmaceutical Sciences, Liaoning University,Shenyang, Liaoning,China
Xirong Jia School of Pharmaceutical Sciences, Liaoning University,Shenyang, Liaoning,China
Abstract
Piperlongumine (PL) is a biologically active alkaloid derived from peppers, has significant cytotoxic effects on cancer with no cytotoxicity. This study used NabTM technology to prepare PL albumin nanoparticles (PL-BSA-NPs) to improve water solubility and bioavailability. We carried out a pharmacological evaluation of the PL-BSA-NPs. The morphological profile of the PL-BSA-NPs was relatively uniform, with an average particle size of approximately 210 nm, with drug load of 2.1%, and encapsulation rate of 87.6%. PL-BSA-NPs were stable for 4 weeks when stored at 4°C. In vitro release behavior of the PL-BSA-NPs showed a sustained release, with a cumulative release of 67.24% in approximately 24 hours. The pharmacokinetic properties of PL-BSA-NPs were shown that PL-BSA-NPs could maintain a certain level of blood drug concentration for a long time, thus demonstrating the sustained release and increased bioavailability of PL. Finally, we investigated the in vitro antitumor activity of the PL-BSA-NPs and found that PL can significantly inhibit HepG2 cell proliferation, and that PL-BSA-NPs enhanced the inhibitory effect of PL on this proliferative effect. Thus, we concluded that PL can destroy liver cancer cells by increasing ROS levels. These results suggested that PL-BSA-NPs show promising potential as a targeted anti-tumor drug.
Publication Details
Page(s) 483-490
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 36, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
Pharmacokinetics, antitumor effect, albumin nanoparticles, Piperlongumine, NabTM technology
0

Citations

0

Downloads

223

Views